Your browser doesn't support javascript.
loading
Structure activity relationship of substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-4).
Singh, Sheo B; Kaelin, David E; Wu, Jin; Miesel, Lynn; Tan, Christopher M; Meinke, Peter T; Olsen, David B; Lagrutta, Armando; Wei, Changqing; Peng, Xuanjia; Wang, Xiu; Fukuda, Hideyuki; Kishii, Ryuta; Takei, Masaya; Shibata, Takeshi; Ohata, Kohei; Takano, Hisashi; Kurasaki, Haruaki; Takeuchi, Tomoko; Nishimura, Akinori; Fukuda, Yasumichi.
Afiliação
  • Singh SB; Merck Research Laboratories, Kenilworth, NJ 07033, United States. Electronic address: sheo.singh.215@gmail.com.
  • Kaelin DE; Merck Research Laboratories, Kenilworth, NJ 07033, United States.
  • Wu J; Merck Research Laboratories, Kenilworth, NJ 07033, United States.
  • Miesel L; Merck Research Laboratories, Kenilworth, NJ 07033, United States.
  • Tan CM; Merck Research Laboratories, Kenilworth, NJ 07033, United States.
  • Meinke PT; Merck Research Laboratories, Kenilworth, NJ 07033, United States.
  • Olsen DB; Merck Research Laboratories, West Point, PA 19486, United States.
  • Lagrutta A; Merck Research Laboratories, West Point, PA 19486, United States.
  • Wei C; WuXi AppTec, Shanghai, People's Republic of China.
  • Peng X; WuXi AppTec, Shanghai, People's Republic of China.
  • Wang X; WuXi AppTec, Shanghai, People's Republic of China.
  • Fukuda H; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Kishii R; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Takei M; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Shibata T; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Ohata K; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Takano H; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Kurasaki H; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Takeuchi T; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Nishimura A; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan.
  • Fukuda Y; Kyorin Pharmaceutical Co., Ltd, 2399-1, Nogi, Nogi-machi, Shimotsuga-gun, Tochigi 329-0114, Japan. Electronic address: yasumichi.fukuda@gmail.com.
Bioorg Med Chem Lett ; 25(11): 2409-15, 2015 Jun 01.
Article em En | MEDLINE | ID: mdl-25911300
ABSTRACT
Bacterial resistance is rapidly growing, necessitating the need to discover new agents. Novel bacterial topoisomerase inhibitors (NBTIs) are new class of broad-spectrum antibacterial agents targeting bacterial DNA gyrase and topoisomerase IV. This class of inhibitors binds to an alternative binding site relative to fluoroquinolones and shows no cross-resistance to quinolones. NBTIs consist of three structural motifs. A structure activity relationship of the left hand motif 1,5-naphthyridine of oxabicyclooctane-linked NBTIs is described. Fifty five compounds were evaluated against a panel of key Gram-positive and Gram-negative strains of bacteria, as well as for hERG activity and five compounds were tested for in vivo efficacy in murine model of Staphylococcus aureus infection. These studies suggest that only a narrow range (activating and deactivating) of substitutions at C-2 and C-7 are tolerated for optimal antibacterial activity and spectrum. An alkoxy (methoxy) and CN at C-2, and a halogen and hydroxyl at C-7, appeared to be preferred in this series. Substitutions on the other three carbons generally have detrimental effect on the activity. No clear hERG activity SAR emerged from these substitutions.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Staphylococcus aureus / DNA Topoisomerases / Inibidores da Topoisomerase Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Staphylococcus aureus / DNA Topoisomerases / Inibidores da Topoisomerase Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article